Literature DB >> 17164231

Metastin (KISS-1) and metastin-coupled receptor (GPR54) expression in transitional cell carcinoma of the bladder.

G Nicolle, E Comperat, N Nicolaïew, G Cancel-Tassin, O Cussenot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17164231     DOI： 10.1093/annonc/mdl421

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  12 in total

Review 1.  Kisspeptin signalling in the physiology and pathophysiology of the urogenital system.

Authors:  Fazal Wahab; Bibi Atika; Muhammad Shahab; Rüdiger Behr
Journal:  Nat Rev Urol       Date:  2015-12-01       Impact factor: 14.432

2.  Metastin is not involved in metastatic potential of non-small cell lung cancer.

Authors:  Eleni M Karapanagiotou; Kalliopi D Dilana; Ioannis Gkiozos; Ioannis Gratsias; Sotirios Tsimpoukis; Aris Polyzos; Kostas N Syrigos
Journal:  Med Oncol       Date:  2010-03-06       Impact factor: 3.064

3.  Regulation of embryonic kidney branching morphogenesis and glomerular development by KISS1 receptor (Gpr54) through NFAT2- and Sp1-mediated Bmp7 expression.

Authors:  Tingfang Yi; Kunrong Tan; Sung-Gook Cho; Ying Wang; Jian Luo; Wenzheng Zhang; Dali Li; Mingyao Liu
Journal:  J Biol Chem       Date:  2010-04-07       Impact factor: 5.157

4.  KISS1 methylation and expression as tumor stratification biomarkers and clinical outcome prognosticators for bladder cancer patients.

Authors:  Virginia Cebrian; Marta Fierro; Esteban Orenes-Piñero; Laura Grau; Patricia Moya; Thorsten Ecke; Miguel Alvarez; Marta Gil; Ferran Algaba; Joaquin Bellmunt; Carlos Cordon-Cardo; James Catto; Antonio López-Beltrán; Marta Sánchez-Carbayo
Journal:  Am J Pathol       Date:  2011-06-17       Impact factor: 4.307

5.  Differential protein expression profiling by iTRAQ-two-dimensional LC-MS/MS of human bladder cancer EJ138 cells transfected with the metastasis suppressor KiSS-1 gene.

Authors:  Isabel Ruppen; Laura Grau; Esteban Orenes-Piñero; Keith Ashman; Marta Gil; Ferrán Algaba; Joaquin Bellmunt; Marta Sánchez-Carbayo
Journal:  Mol Cell Proteomics       Date:  2010-02-05       Impact factor: 5.911

6.  Metastin has potential as a suitable biomarker and novel effective therapy for cancer metastasis (Review).

Authors:  Sunao Shoji; Xian Yang Tang; Haruhiro Sato; Yukio Usui; Toyoaki Uchida; Toshiro Terachi
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

7.  Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation.

Authors:  Sung-Gook Cho; Zhengfang Yi; Xiufeng Pang; Tingfang Yi; Ying Wang; Jian Luo; Zirong Wu; Dali Li; Mingyao Liu
Journal:  Cancer Res       Date:  2009-08-11       Impact factor: 12.701

8.  KiSS-1 methylation and protein expression patterns contribute to diagnostic and prognostic assessments in tissue specimens for colorectal cancer.

Authors:  Patricia Moya; Sergio Esteban; Antonio Fernandez-Suarez; Marisa Maestro; Manuel Morente; Marta Sánchez-Carbayo
Journal:  Tumour Biol       Date:  2012-11-07

9.  Expression of preoperative KISS1 gene in tumor tissue with epithelial ovarian cancer and its prognostic value.

Authors:  Fang Cao; Liping Chen; Manhua Liu; Weiwei Lin; Jinlong Ji; Jun You; Fenghai Qiao; Hongbin Liu
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

10.  Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma.

Authors:  Leah M Prentice; Christian Klausen; Steve Kalloger; Martin Köbel; Steven McKinney; Jennifer L Santos; Challayne Kenney; Erika Mehl; C Blake Gilks; Peter Leung; Ken Swenerton; David G Huntsman; Samuel A J Aparicio
Journal:  BMC Med       Date:  2007-11-15       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.